Dexcom takes G6 CGM to SingaporeGlobal CGM device maker Dexcom has launched its latest CGM system in Singapore.
Distributed through its partner DKSH Singapore, the prick-less Dexcom G6 CGM uses a wearable sensor and transmitter…
February 23, 2023 Headlines No Comments Teladoc (TDOC) Reports Q4 Loss, Tops Revenue Estimates
Teladoc Health reports a $13.7 billion loss for FY 2022, and mixed revenue and earnings results for Q4, prompting…
Medicare Advantage enrollment grew to 29.5 million people for the 2023 plan year, now representing 46% of total Medicare enrollment, according to a Tuesday report from The Chartis Group. However, enrollment is growing at…
Continue Reading
Top News
Teladoc Health reports Q4 results: revenue up 15%, EPS –$0.23 versus –$0.07, beating revenue expectations but falling short on earnings.
The company reported a staggering $13.7 billion loss for FY 2022, much of…
It’s no secret that American teenagers — especially girls — are experiencing challenges with their mental health. The last several years have been tumultuous for younger populations due to the Covid-19 pandemic. But new…
Continue Reading
When the organization accomplishes milestones such as HITRUST certification, he says, that information is shared with the insurance provider and becomes part of how UPMC’s premiums are calculated.“Over the past few years especially, I’ve…
Continue Reading
In the “not a major surprise, but it’s nice to see some data” category, a recent study published in the Journal Healthcare finds that scribes are linked to a 27% reduction in primary care…
Continue Reading
Value-based care startup Vytalize Health garnered a whopping $100 million in funding.Monroe Capital and Enhanced Healthcare Partners led the round with participation from North Coast Ventures.
WHAT THEY DO
Vytalize Health offers independent primary care practices…
What You Should Know:– Vytalize Health, a leading risk-bearing provider enablement platform, announced it has closed $100 million in funding led by Enhanced Healthcare Partners and Monroe Capital, with participation from North Coast Ventures.–…
Continue Reading
What You Should Know:– Tempus, the $10B artificial intelligence and precision medicine company, announced their first multi-omics collaboration with Actuate Therapeutics, in which datasets of different omic groups – genomics, transcriptomics, epigenomics, and others…
Continue Reading
